BMK_PANC
Multi-institutional study on the definition of new predictive biomarkers of response in resectable pancreatic adenocarcinoma, with poor prognostic factors, treated with neoadjuvants. Serum pharmacoproteomic correlation of response to treatment. Development of a prognostic/predictive biosensor from this experience.
Project partners
Project manager : Antonio VIUDEZ
Navarrabiomed – Miguel Servet Foundation
Researchers or companies, wish to join the REFBIO network?